The Role of Bimatoprost in Graves' Periorbitopathy

Johns Hopkins University

Summary

Testing whether Bimatoprost, a topical eye drop used for glaucoma, can be used to induce periorbital fat atrophy in patients with Graves' disease

Eligibility

Age range: 18+ years
Sex: All
Healthy volunteers: No

Detailed criteria

Inclusion Criteria: Graves' Ophthalmopathy with Exophthalmos/Proptosis - Exclusion Criteria: Active Graves Disease, Currently pregnant, Taking Steroids \-

Interventions

Drug
Bimatoprost Ophthalmic
Bimatoprost, aka Lumigan, one drop in one eye nightly

Location

University of Washington
Seattle, Washington
avanbrum@uw.edu 206-543-7250

Summary

Eligibility

Interventions

Location

Conditions